Robert A Hallewell

Title: The Innovations of Robert A Hallewell

Introduction

Robert A Hallewell is a prominent inventor based in San Francisco, CA. He holds a total of 16 patents, showcasing his significant contributions to the field of biotechnology. His work primarily focuses on the cloning and expression of superoxide dismutase, an important enzyme in cellular defense mechanisms.

Latest Patents

Among his latest patents, Hallewell has developed methods for the cloning and expression of manganese superoxide dismutase in microorganisms. His DNA construct comprises a vector for the expression of human cytoplasmic Cu/Zn superoxide dismutase in E. coli, along with methods for enhancing the efficiency of expression. The gene encoding human superoxide dismutase is isolated and inserted into a vector with a synthetic linker, which improves translation efficiency. Notably, strain D1210 (pSODX8) was deposited at the A.T.C.C. on September 27, 1983, and assigned Accession No. 39453. Additionally, yeast strain 2150-2-3 (pC1/1GAPSOD) and strains D1210 (pSOD11) and D1210 (pS20R) were deposited at the A.T.C.C. on May 9, 1984, receiving Accession Nos. 20708, 39679, and 39680, respectively.

Career Highlights

Hallewell has had a distinguished career, working with notable organizations such as Chiron Corporation and the University of California. His innovative research has significantly advanced the understanding of superoxide dismutase and its applications in biotechnology.

Collaborations

Throughout his career, Hallewell has collaborated with esteemed colleagues, including Guy T Mullenbach and Pablo D Valenzuela. These partnerships have further enriched his research and contributions to the field.

Conclusion

Robert A Hallewell's work in the field of biotechnology, particularly in the area of superoxide dismutase, has led to numerous patents and advancements in scientific research. His innovative spirit and collaborative efforts continue to influence the industry today.